DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Heparin sodiumis the generic ingredient in thirty-eight branded drugs marketed by Hospira, Intl Medication, Luitpold, Parke Davis, Smith And Nephew, Solopak, Abraxis Pharm, Akorn, B Braun Medical Inc, Casi Pharms Inc, Chamberlin Parenterl, Dell Labs, Dr Reddys, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hospira Inc, Lilly, Mylan Labs Ltd, Nanjing King-friend, Organon Usa Inc, Pfizer, Pharm Spec, Pharmacia And Upjohn, Sagent Pharms, Sandoz, Shenzhen Techdow, Watson Labs Inc, West-ward Pharms Int, Baxter Hlthcare, Mcgaw, B Braun, Pharma Serve Ny, and 3M, and is included in eighty NDAs. Additional information is available in the individual branded drug profile pages.
There are seventy-seven drug master file entries for heparin sodium. Eighteen suppliers are listed for this compound.
Recent Clinical Trials for heparin sodium
Identify potential brand extensions & 505(b)(2) entrants
|Hospital General “Dr. Miguel Silva” de Morelia||Phase 4|
|NAUSLIFE HEMODIALYSIS CLINICS||Phase 4|
|Universidad Nacional Autonoma de Mexico||Phase 4|
Pharmacology for heparin sodium
|Drug Class||Anti-coagulant |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|B Braun Medical Inc||HEPARIN SODIUM||heparin sodium||INJECTABLE;INJECTION||208827-001||Nov 19, 2018||RX||No||No||Start Trial||Start Trial||Start Trial|
|West-ward Pharms Int||HEPARIN SODIUM||heparin sodium||INJECTABLE;INJECTION||017007-005||Approved Prior to Jan 1, 1982||DISCN||Yes||No||Start Trial||Start Trial||Start Trial|
|Mylan Labs Ltd||HEPARIN SODIUM||heparin sodium||INJECTABLE;INJECTION||203851-002||Nov 30, 2017||AP||RX||No||No||Start Trial||Start Trial||Start Trial|
|B Braun||HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER||heparin sodium||INJECTABLE;INJECTION||019135-001||Mar 29, 1985||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.